Bharat B. Aggarwal

Research interests

Publications

• Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition) 1

  Autophagy · 2021 · https://doi.org/10.1080/15548627.2020.1797280

• Natural products in drug discovery: advances and opportunities

  Nature Reviews Drug Discovery · 2021 · https://doi.org/10.1038/s41573-020-00114-z

• Curcumin, the golden nutraceutical: multitargeting for multiple chronic diseases

  British Journal of Pharmacology · 2016 · 10.1111/bph.13621

• Therapeutic Roles of Curcumin: Lessons Learned from Clinical Trials

  The AAPS Journal · 2012 · 10.1208/s12248-012-9432-8

• Oxidative stress, inflammation, and cancer: How are they linked?

  Free Radical Biology and Medicine · 2010 · https://doi.org/10.1016/j.freeradbiomed.2010.09.006

• Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer

  Clinical Cancer Research · 2008 · 10.1158/1078-0432.ccr-08-0024

• Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins

  Cancer Letters · 2008 · 10.1016/j.canlet.2008.03.009

• Cancer is a Preventable Disease that Requires Major Lifestyle Changes

  Pharmaceutical Research · 2008 · 10.1007/s11095-008-9661-9

• Curcumin and cancer: An “old-age” disease with an “age-old” solution

  Cancer Letters · 2008 · 10.1016/j.canlet.2008.03.025

• Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases

  The International Journal of Biochemistry & Cell Biology · 2008 · 10.1016/j.biocel.2008.06.010

• Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets

  Trends in Pharmacological Sciences · 2008 · 10.1016/j.tips.2008.11.002

• Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature

  Biochemical Pharmacology · 2008 · 10.1016/j.bcp.2008.08.008

• Bioavailability of Curcumin: Problems and Promises

  Molecular Pharmaceutics · 2007 · https://doi.org/10.1021/mp700113r

• Curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetrahydrocurcumin and turmerones differentially regulate anti-inflammatory and anti-proliferative responses through a ROS-independent mechanism

  Carcinogenesis · 2007 · https://doi.org/10.1093/carcin/bgm123

• Curcumin as “Curecumin”: From kitchen to clinic

  Biochemical Pharmacology · 2007 · 10.1016/j.bcp.2007.08.016

• CURCUMIN: THE INDIAN SOLID GOLD

  Advances in experimental medicine and biology · 2007 · 10.1007/978-0-387-46401-5_1

• Inflammation and cancer: How hot is the link?

  Biochemical Pharmacology · 2006 · 10.1016/j.bcp.2006.06.029

• Molecular targets of dietary agents for prevention and therapy of cancer

  Biochemical Pharmacology · 2006 · 10.1016/j.bcp.2006.02.009

• Nuclear factor-κB

  Cancer Cell · 2004 · 10.1016/j.ccr.2004.09.003

• Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.

  PubMed · 2004

• Anticancer potential of curcumin: preclinical and clinical studies.

  PubMed · 2003

• Signalling pathways of the TNF superfamily: a double-edged sword

  Nature reviews. Immunology · 2003 · https://doi.org/10.1038/nri1184

• Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B.

  Proceedings of the National Academy of Sciences · 1996 · 10.1073/pnas.93.17.9090

• Activation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane)

  Journal of Biological Chemistry · 1995 · 10.1074/jbc.270.42.24995

• Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in Vitro

  Science · 1985 · 10.1126/science.3933111

• Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin

  Nature · 1984 · 10.1038/312724a0

Current projects

No projects listed.